Herold Advisors
GSK icon

Herold Advisors’s GSK GSK Stock Holding History

Herold Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$403K Sell
8,361
-852
-9% -$43.5K 0.08% 195
2026
Q2 		$484K Buy
9,213
+862
+10% +$45.6K 0.1% 179
2026
Q1 		$461K Buy
8,351
+240
+3% +$13K 0.1% 182
2025
Q4 		$398K Sell
8,111
-774
-9% -$36.1K 0.09% 184
2025
Q3 		$383K Sell
8,885
-1,548
-15% -$60.5K 0.09% 180
2025
Q2 		$401K Buy
10,433
+634
+6% +$24.2K 0.08% 206
2025
Q1 		$380K Sell
9,799
-360
-4% -$13.2K 0.08% 198
2024
Q4 		$344K Sell
10,159
-139
-1% -$5K 0.07% 208
2024
Q3 		$421K Sell
10,298
-395
-4% -$16.2K 0.09% 200
2024
Q2 		$412K Sell
10,693
-234
-2% -$9.8K 0.1% 196
2024
Q1 		$469K Buy
10,927
+246
+2% +$10.1K 0.11% 185
2023
Q4 		$396K Buy
10,681
+511
+5% +$18.3K 0.11% 182
2023
Q3 		$369K Sell
10,170
-9
-0.1% -$319 0.11% 183
2023
Q2 		$363K Sell
10,179
-372
-4% -$13.3K 0.11% 181
2023
Q1 		$375K Sell
10,551
-4,091
-28% -$143K 0.13% 161
2022
Q4 		$515K Sell
14,642
-11,916
-45% -$397K 0.22% 110
2022
Q3 		$781K Sell
26,558
-1,030
-4% -$39K 0.38% 88
2022
Q2 		$1.5M Buy
27,588
+1,226
+5% +$67.7K 0.67% 46
2022
Q1 		$1.44M Buy
26,362
+10,515
+66% +$571K 0.51% 64
2021
Q4 		$873K Buy
15,847
+2,083
+15% +$108K 0.34% 95
2021
Q3 		$657K Buy
+13,764
New +$691K 0.26% 104

Other funds holding GSK

Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
ABC Arbitrage
ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return
Sound Income Strategies
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
Euro Pacific Asset Management
Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return
Keystone Financial Planning
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
Bell Bank
Bell Bank Fargo, North Dakota $2.66B AUM 18.07% 1-Year Est. Return

Herold Advisors's GSK Position: Q3 2026 in Review

Herold Advisors reduced its GSK (GSK) stake by 9.2% in Q3 2026, selling an estimated $43.5K and leaving 8,361 shares worth $403K. The position accounts for 0.08% of the portfolio, ranked #195.

Herold Advisors first reported a position in GSK in Q3 2021 and has held it in 21 quarters since. The position peaked at $1.5M in Q2 2022. 266 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Herold Advisors held 8,361 shares of GSK worth $403K as of Q3 2026.
  • Herold Advisors sold 852 GSK shares in Q3 2026, an estimated $43.5K.
  • GSK made up 0.08% of Herold Advisors's portfolio in Q3 2026, its #195 holding.
  • Herold Advisors first reported a position in GSK in Q3 2021 and has held it in 21 quarters since.
  • Herold Advisors's GSK position peaked at $1.5M in Q2 2022.
  • 266 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Herold Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.